Both in Pharmaceuticals
United Therapeutics vs Roivant Sciences
Over the past year UTHR returned +34.4% and ROIV returned +84.6%; their daily moves had a correlation of 0.22.
UTHR +34.4% ROIV +84.6%Growth of $1, one year, split-adjusted
| Metric | UTHR | ROIV |
|---|---|---|
| Price | $598.72 | $36.91 |
| Market cap | $25.68B | $26.66B |
| Today | +0.87% | −1.63% |
| 1 month | +4.8% | +4.0% |
| 6 months | +5.0% | +32.6% |
| Year to date | +22.9% | +70.1% |
| 1 year | +31.5% | +96.7% |
| Revenue growth (YoY) | −1.9% | −33.5% |
| Gross margin | 87.3% | 100.0% |
| Net margin | 42.5% | −13164.8% |
| P/E (TTM) | 19.6× | — |
| Price / sales | 8.1× | 3,539.7× |
| Net cash | $2.66B | $3.84B |
| Dividend yield | — | — |
| Volatility (60d) | 37.7% | 49.2% |
| Short % of float | 5.9% | 8.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).